New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:01 EDTCRMECardiome announces commercializatoin partnership for Aggrastat
Cardiome announced an agreement with AOP Orphan Pharmaceuticals AG, headquartered in Vienna, Austria, to commercialize Aggrastat in selected European markets. AOP Orphan will be responsible for the commercialization of Aggrastat in the AOP Orphan countries. Under terms of the agreement, AOP Orphan has agreed to specific annual commercial goals for Aggrastat. Financial details of the agreement were not disclosed.
News For CRME From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 27, 2016
08:11 EDTCRMECardiome announces filing of orphan drug application for oral Vernakalant
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use